SEC Form 4 · accession 0001209191-15-050774
Eiger BioPharmaceuticals, Inc. · EIGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregg H Alton
Director
Period of report
Jun 4, 2015
Accepted (ET)
Jun 5, 2015 · 6:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001305253
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1,F2 | $2.16 | Jun 4, 2015 | A | 10,000 | A | Jul 4, 2015 | Jun 3, 2025 | Common Stock | 10,000 | 40,000 | D |
Explanation of responses
- F1Automatic grant of stock option under the Issuer's 2013 Equity Incentive Plan pursuant to the non-employee director compensation program.
- F2The stock option award vests in equal monthly installments until the Issuer's next annual stockholder meeting.